VIM and hepatocellular carcinoma: The authors measured MALAT1 and vimentin expression levels in paired HCC and normal adjacent tissues by RT-PCR and predicted potential miR-30a-5p binding sites in MALAT1 and the target site of miR-30a-5p in vimentin using bioinformatic analyses.